• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Trump selects Stanford professor to be next NIH director

Trump selects Stanford professor to be next NIH director

November 27, 2024 By Chris Newmarker

This is a Stanford University portrait photo of Dr. Jay Bhattacharya whom President-elect Donal Trump has nominated as the next director of the Nation Institutes of Health or NIH. 
Dr. Jay Bhattacharya of Stanford University is President-elect Donald Trump’s nominee to be the next director of the NIH. [Image courtesy of Stanford University]
President-elect Donald Trump has selected Stanford University physician and economist Dr. Jay Bhattacharya as director of the National Institutes of Health.

Bhattacharya criticized U.S. public health policies during the COVID-19 pandemic, including lockdowns and vaccine mandates. He joins other notable pandemic policy critics whom Trump has nominated for medical-related leadership posts in his second administration: Robert F. Kennedy Jr. for Health and Human Services Department secretary, Johns Hopkins University surgeon Dr. Martin Makary for FDA commissioner, and former Columbia University surgeon and television personality Dr. Mehmet Oz for CMS administrator.

In a statement shared yesterday, Trump said that Bhattacharya would work with RFK Jr. to restore the NIH to a gold standard of medical research, tackling underlying causes and solutions for America’s biggest health challenges, including chronic diseases. “Together, they will work hard to Make America Healthy Again!”

Bhattacharya responded on social media that he was honored and humbled to be nominated.  “We will reform American scientific institutions so that they are worthy of trust again and will deploy the fruits of excellent science to make America healthy again!”

On top of being a professor of medicine at Stanford University, Bhattacharya is the director of the university’s Center on the Demography and Economics of Health and Aging. His research has not only included governments’ COVID-19 responses but also the health and well-being of vulnerable populations, according to his LinkedIn page.

In a post on X, Dr. Ashish K. Jha, the dean of the Brown University School of Public Health who served as President Joe Biden’s COVID-19 coordinator, described Kennedy as a terrible choice but said Bhattacharya, Makary and Oz were all smart and experienced — even as he had policy disagreements with them. Said Jha: “We will need them to do well.”

Filed Under: Featured, Health Technology, Healthcare Reform, Research & Development Tagged With: National Institutes of Health (NIH), Personnel Moves

More recent news

  • Carlsmed names chief product and AI officer as it claims CMS reimbursements
  • Integra LifeSciences says Cincinnati plant flooding will cost millions
  • Mendaera rolls out handheld needle robot paired with Butterfly ultrasound probe
  • Edwards earns FDA approval for first-of-its-kind size-adjustable pediatric heart valve
  • Leading medical device experts and MDO launch Medtech Innovation Board

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy